Conditions: Psychosis Prodrome
Keywords: psychosis schizophrenia prodrome ziprasidone placebo
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 51
Healthy volunteers: no

Brief summary:
This study aims to determine whether ziprasidone is superior to placebo over 24 weeks for patients with the psychosis prodrome.

Detailed description:

Arms:
arm 1: Patients will be treated with Ziprasidone for 6 months arm 2: Patients will be treated with placebo for 6 months

Interventions: intervention 1: ziprasidone intervention 2: placebo
Intervention descriptions: intervention 1: 20-160 mg/d intervention 2: placebo

Protocol document: